2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.
about
New insights on the development of fungal vaccines: from immunity to recent challengesRecent advances in vaccination of non-responders to standard dose hepatitis B virus vaccineImmunization of children with secondary immunodeficiencyPneumococcal vaccine and patients with pulmonary diseasesTravel advice for the immunocompromised traveler: prophylaxis, vaccination, and other preventive measuresBiliary atresia: Indications and timing of liver transplantation and optimization of pretransplant careAdolescent Vaccination Strategies: Interventions to Increase Coverage.Rituximab: A Magic Bullet for PemphigusValidation of a Method to Identify Immunocompromised Patients with Severe Sepsis in Administrative Databases.Preventing and managing HIV infection in infants, children, and adolescents in the United States.Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015.Influenza a outbreak in an ambulatory stem cell transplant center.Immune dysfunction prior to Staphylococcus aureus bacteremia is a determinant of long-term mortality.The ABC of pneumococcal infections and vaccination in patients with chronic kidney disease.Recommendations for Risk Categorization and Prophylaxis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Expert Opinion (TEO-4).Robust Vaccine Responses in Adult and Pediatric Cord Blood Transplantation Recipients Treated for Hematologic Malignancies.Immunocompromised Travelers: Demographic Characteristics, Travel Destinations, and Pretravel Health Care from the U.S. Global TravEpiNet ConsortiumRisk of non-hematologic cancer in individuals with high-count monoclonal B-cell lymphocytosis.Herpes zoster in patients with bullous pemphigoid: a population-based case-control and cohort study.How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantationImmunization practices in acute lymphocytic leukemia and post-hematopoietic stem cell transplant in Canadian Pediatric Hematology/Oncology centers.Multicenter Evaluation of BioFire FilmArray Meningitis/Encephalitis Panel for Detection of Bacteria, Viruses, and Yeast in Cerebrospinal Fluid SpecimensPostsplenectomy Prophylaxis: A Persistent Failure to Meet Standard?Immune reconstitution post allogeneic transplant and the impact of immune recovery on the risk of infection.A guide to prepare patients with inflammatory bowel diseases for anti-TNF-α therapy.Immunization of high-risk paediatric populations: Central European Vaccination Awareness Group recommendations.Immunization after kidney transplantation-what is necessary and what is safe?Live attenuated herpes zoster vaccine for HIV-infected adults.Immunogenicity and safety of influenza vaccination in patients with juvenile idiopathic arthritis on biological therapy using the microneutralization assay.The risk of infections in patients with myelodysplastic syndromes in 2016.Comprehensive Care of the Lung Transplant Patient.Risks of Infection among the Older Inflammatory Bowel Disease Patients.Invasive pneumococcal infections in children following transplantation in the pneumococcal conjugate vaccine era.Routine vaccination practice after adult and paediatric allogeneic haematopoietic stem cell transplant: a survey of UK NHS programmes.Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant ConsortiumFactors affecting immune responses to the influenza vaccine.Immunization practices among pediatric transplant hepatologists.A quality improvement initiative to increase pneumococcal vaccination coverage among children after kidney transplant.Infection Prevention in Transplantation.The importance of immunization in cancer prevention, treatment, and survivorship.
P2860
Q26776056-D7963352-CC83-45A6-9A17-62F8F0ECFBA6Q26777516-D98B9CF5-35C5-4A5D-939F-B246001F3CA4Q26801474-31F855C2-CE57-4038-B1B1-C74AF26536D4Q26825944-6A365098-01CF-4B04-9593-028BAC09C25BQ27687760-556945B6-5211-478E-BDDB-C4E0498D0F4BQ28075831-B9B8F22C-1E6B-4DB1-B600-A37DFAE07FF1Q30251432-859AC63D-9845-4C72-85C3-818C1424532DQ33741941-32EED84E-D85B-470A-88C5-7FF49F3172FBQ33772318-D487AF07-E38F-4086-9230-A816988DEDBFQ33808736-812B1879-EAEA-4FB5-9350-6859808A2557Q34481246-51A56277-2C94-4436-B5EB-8E9295839AFCQ34801940-262720BB-8AF9-4FF5-8F3E-C6A5CBC605F0Q35088590-9EED5102-5943-4CAE-BC2A-43BF42FC3F45Q35633471-0F7E0B8A-FEE6-4DE4-A753-4A0672AD50ABQ35672258-2C9993CD-6681-4599-97C6-574D6528FB04Q36355144-0775892C-69B4-471D-AF9A-8C1EAF6999B8Q36436312-7AB3345A-6BC5-4957-858F-B7B0AEE260C2Q36822986-E07B8CE7-33D3-4FB0-92A5-0CC1EFAADECAQ36923739-E6597101-EDD2-490D-9850-4E5492DD72CDQ36965855-C1AA0645-9E1A-41E0-BF8B-090CE598C7A1Q37130759-E9EC3D05-51D7-4C64-9E29-96D198894705Q37218579-1D95709B-9F80-4B73-9839-CD9223FDD699Q37495102-604C5426-8517-492F-AD03-F5518F700AB8Q37509207-F0267FD7-403A-424E-8DC6-2A46FCABAF13Q37678199-C47710A3-6204-473C-8FE0-52189CA3FC36Q38198120-80107C5B-00B0-433B-9FB5-521B112EAAE4Q38235003-01C53CF4-4069-4442-941B-8F2A5A692526Q38575356-21C7E234-F4E0-467B-A0BD-F2489B1D8272Q38636507-FC5142B6-4515-49DB-826E-CA9D636BD2BDQ38813702-C57FF733-E2A2-4A6B-AA8F-217D747539A1Q38978203-B30F1F91-7CD7-4E4A-8D30-DA7CF01C260EQ39159953-AF12DAEF-A2BB-428D-B816-0022B5A9CC55Q39174727-BEAA7791-4CAD-482D-B8F3-4EFA565F52AFQ39251542-9C6D7A72-639A-4807-A8FE-0F39A5F2D050Q39289010-4AAC0576-245D-4F26-AB42-8ECDFCE7CBF2Q39375320-61C2B94C-55F9-4C5B-B34E-D326DB163939Q39568995-E03C539A-C04F-47F9-91BE-32E4FB0713CDQ39662181-7102228C-4A22-4643-A110-40DCCE91BAE0Q40049276-71ACE79F-57B3-4A69-9B1C-34EB73AC76C6Q40104207-F4167C36-05A9-4E51-ACF4-F4E4F6914886
P2860
2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.
@ast
2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.
@en
2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.
@nl
type
label
2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.
@ast
2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.
@en
2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.
@nl
prefLabel
2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.
@ast
2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.
@en
2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.
@nl
P2093
P2860
P50
P356
P1476
2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.
@en
P2093
Athos Bousvaros
E Graham Davies
Insoo Kang
Lillian Sung
Lorry G Rubin
Marcie Tomblyn
Myron J Levin
Robin Avery
Shireesha Dhanireddy
P2860
P304
P356
10.1093/CID/CIT684
P407
P577
2013-12-04T00:00:00Z